The results of the cytoplasmic and nuclear protein separation assays demonstrated the presence of IGF2BP3 in the nucleus, whereas its levels were increased in HBV/HBx-expressing HCC cells (Fig. 5F). Here, IGF2BP3 is linked to hepatocellular carcinoma.